# Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest

> **NCT05554978** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 32 (estimated)

## Conditions studied

- Cardiac Arrest

## Interventions

- **DRUG:** Landiolol
- **DRUG:** Sodium Chloride (NaCl) 0.9%

## Key facts

- **NCT ID:** NCT05554978
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-03
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2023-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05554978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05554978, "Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05554978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*